Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Salvatora Tindara Miano"'
Autor:
Maria Palmieri, Margherita Baldassarri, Francesca Fava, Alessandra Fabbiani, Elisa Gelli, Rossella Tita, Pamela Torre, Roberto Petrioli, Theodora Hadijstilianou, Daniela Galimberti, Elisa Cinotti, Carmelo Bengala, Marco Mandalà, Pietro Piu, Salvatora Tindara Miano, Ignazio Martellucci, Agnese Vannini, Anna Maria Pinto, Maria Antonietta Mencarelli, Stefania Marsili, Alessandra Renieri, Elisa Frullanti
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 2052-2061 (2020)
Abstract Background Although the efficacy of molecularly target agents in vitro, their use in routine setting is limited mainly to the use of anti‐HER2 and antiEGFR agents in vivo. Moreover, core biopsy of a single cancer site may not be representa
Externí odkaz:
https://doaj.org/article/a0230e7ee72545a5aa954b6cc471ae92
Autor:
Gabriella Doddato, Floriana Valentino, Annarita Giliberti, Filomena Tiziana Papa, Rossella Tita, Lucia Pia Bruno, Sara Resciniti, Chiara Fallerini, Elisa Benetti, Maria Palmieri, Maria Antonietta Mencarelli, Alessandra Fabbiani, Mirella Bruttini, Alfredo Orrico, Margherita Baldassarri, Francesca Fava, Diego Lopergolo, Caterina Lo Rizzo, Vittoria Lamacchia, Sara Mannucci, Anna Maria Pinto, Aurora Currò, Virginia Mancini, Oncologic Multidisciplinary Team, Azienda Ospedaliera Universitaria Senese, Oncologic Multidisciplinary Team, Azienda Usl Toscana Sud Est, Francesca Mari, Alessandra Renieri, Francesca Ariani, Alessandro Neri, Donato Casella, Andrea Bernini, Stefania Marsili, Roberto Petrioli, Salvatora Tindara Miano, Alessandra Pascucci, Ignazio Martellucci, Monica Crociani, Marta Vannini, Federica Fantozzi, Andrea Stella, Alessia Carmela Tripodi, Angelamaria Giusti, Alfonso Fausto, Lucia Mantovani, Francesca Belardi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Hereditary Breast and Ovarian Cancer (HBOC) syndrome is a condition in which the risk of breast and ovarian cancer is higher than in the general population. The prevalent pathogenesis is attributable to inactivating variants of the BRCA1-2 highly pen
Externí odkaz:
https://doaj.org/article/ca4532e26c24440eb12237fb2fc7eb0a
Autor:
Filippo Francini, Alessandra Pascucci, Edoardo Francini, Gianluca Bargagli, Raffaele Conca, Antonella Licchetta, Giandomenico Roviello, Ignazio Martellucci, Giorgio Chiriacò, Salvatora Tindara Miano, Giuseppe Marzocca, Antonio Manganelli, Roberto Ponchietti, Vinno Savelli, Roberto Petrioli
Publikováno v:
Prostate Cancer, Vol 2011 (2011)
Background. The aim of this paper was to evaluate the activity and tolerability of docetaxel (D) and bevacizumab (Bev) in patients with metastatic castrate-resistant prostate cancer (CRPC) previously exposed to D. Methods. Treatment consisted of D 30
Externí odkaz:
https://doaj.org/article/a1065ac7a88d406a9d014508519fdb43
Autor:
Pietro Piu, Elisa Gelli, Margherita Baldassarri, Elisa Frullanti, Marco Mandalà, Elisa Cinotti, Alessandra Fabbiani, Maria Palmieri, Francesca Fava, Anna Maria Pinto, Roberto Petrioli, Pamela Torre, Maria Antonietta Mencarelli, Alessandra Renieri, Carmelo Bengala, Agnese Vannini, Stefania Marsili, Salvatora Tindara Miano, Daniela Galimberti, Theodora Hadijstilianou, Ignazio Martellucci, Rossella Tita
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 6, Pp 2052-2061 (2020)
Cancer Medicine, Vol 9, Iss 6, Pp 2052-2061 (2020)
Background Although the efficacy of molecularly target agents in vitro, their use in routine setting is limited mainly to the use of anti‐HER2 and antiEGFR agents in vivo. Moreover, core biopsy of a single cancer site may not be representative of t
Autor:
Marta Banchi, Serina Batson, Claudio Bisegna, Guido Bocci, Rosa Angela Cardone, Martina Catalano, Valerio Ciccone, Vanessa Desantis, Beatrice Detti, Antonello Di Paolo, Sandra Donnini, Arianna Filippelli, Giulio Francia, Maria Antonia Frassanito, Maria Frosini, Ilaria Camilla Galli, Diana Gonzalez Garcia, Michele Guida, Ester Illiano, Tomas Koltai, Aurelia Lamanuzzi, Ida Landini, Andrea Lapucci, Andrea Liaci, Ignazio Martellucci, Salvatora Tindara Miano, Enrico Mini, Monica Montagnani, Lucia Morbidelli, Gabriella Nesi, Stefania Nobili, Roberto Petrioli, Davide Quaresmini, Gloria Ravegnini, Stephan Joel Reshkin, Domenico Ribatti, Emma Ristori, Giandomenico Roviello, Ilaria Saltarella, Simona Saponara, Francesco Sessa, Pietro Spatafora, Andrea Spini, Angelo Vacca, Lorenzo Verdelli, Graziano Vignolini, Donata Villari, Marina Ziche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2fa82cc43be7c0a55d4e8c53a3585e1
https://doi.org/10.1016/b978-0-323-90190-1.09986-8
https://doi.org/10.1016/b978-0-323-90190-1.09986-8
Autor:
Edoardo Francini, Virginia Livellara, Steven R. Alberts, Guido Francini, Guido Pesola, Eric G. Wolfe, Fang-Shu Ou, Joleen M. Hubbard, Elena Colombo, Sara Cherri, Roberto Petrioli, Luciana Messuti, Stefano Lazzi, Salvatora Tindara Miano, Harry H. Yoon, Andrea Giovanni Multari, Serena Bazzurri
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 2, Pp 100973-(2021)
Translational Oncology, Vol 14, Iss 2, Pp 100973-(2021)
Highlights • Low CD3+ TILs rate was associated with shorter OS in those with stage II colon cancer who did not receive adjuvant therapy. • CD3+ TILs rate was not prognostic for patients with stage II colon cancer who had adjuvant therapy. • Low
We report the case of a heavily pretreated male subject affected by left funiculus liposarcoma and successfully treated with eribulin mesylate. After three surgical interventions, radiotherapy on the lesion of the penile bulb for satellite nodules an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0a3ce702bcfbd3d9903a7cfe7b6df1
http://hdl.handle.net/11365/1095201
http://hdl.handle.net/11365/1095201
Autor:
Loretta Paolelli, Guido Pesola, Pamela Torre, Ignazio Martellucci, Salvatora Tindara Miano, Guido Francini, Giovanni Paganini, Roberto Petrioli, Edoardo Francini
Objectives The aim of this study was to evaluate the efficacy and safety of the combination Gemcitabine (Gem) plus nab-Paclitaxel (NabP) (Gem/NabP), followed by maintenance Gem in older adults with locally advanced or metastatic pancreatic cancer (PC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d92c41d6b6a2eeb16042f626927f5bfa
http://hdl.handle.net/2158/1210191
http://hdl.handle.net/2158/1210191
Publikováno v:
Medical Hypotheses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ea990c91eb5e5a5806aaf42aa2d113
http://hdl.handle.net/11365/1120269
http://hdl.handle.net/11365/1120269